.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Moodys
Farmers Insurance
Johnson and Johnson
Covington
Boehringer Ingelheim
Fuji
Accenture
Julphar
Express Scripts

Generated: July 21, 2017

DrugPatentWatch Database Preview

REZULIN Drug Profile

« Back to Dashboard

What is the patent landscape for Rezulin, and when can generic versions of Rezulin launch?

Rezulin is a drug marketed by Pfizer Pharms and is included in one NDA.

The generic ingredient in REZULIN is troglitazone. Additional details are available on the troglitazone profile page.

Summary for Tradename: REZULIN

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list51
Clinical Trials: see list1
Patent Applications: see list6,092
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:REZULIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720-001Jan 29, 1997DISCNNoNo► Subscribe► Subscribe
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720-003Aug 4, 1997DISCNNoNo► Subscribe► Subscribe
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720-002Jan 29, 1997DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: REZULIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720-003Aug 4, 19976,046,202► Subscribe
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720-001Jan 29, 19975,602,133► Subscribe
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720-001Jan 29, 19976,046,202► Subscribe
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720-002Jan 29, 19975,602,133► Subscribe
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720-001Jan 29, 19974,572,912► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
Fish and Richardson
Fuji
Medtronic
Harvard Business School
McKesson
Colorcon
Teva
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot